Delic Holdings Corp. (DELCF)

Overview

Delic Holdings Corp. is a pioneering company in the realm of psychedelic and cannabis medicine and treatment, with operations spanning across the United States and Canada. The company stands at the forefront of the psychedelic culture dialogue through its array of creative platforms and educational resources. Delic Holdings Corp. is not only dedicated to promoting public discourse on psychedelics but also leads in the development of intellectual property via research and development within the cannabis and psychedelics industry. The company is proud to offer groundbreaking treatments through its ketamine infusion treatment clinics, marking a significant contribution to mental health and wellness. Headquartered in Vancouver, Canada, Delic Holdings Corp. continues to expand its reach and impact in the realm of psychedelic medicine.

Products and Services

• The Delic:

A creative platform that hosts and fosters public discourse about psychedelic culture, The Delic serves as a cornerstone for discussions, art, and thought leadership within the psychedelic community.

• Meet Delic:

This event-based initiative promotes various topics related to psychedelics, including safety, harm reduction, the interplay between Hollywood and psychedelics, mental health, the significance of integration into everyday life, human performance enhancements, and advancements in psychedelic medicine.

• Reality Sandwich:

As a public online education platform, Reality Sandwich offers an extensive collection of content, tallying approximately 10,000 pieces, with psychedelic guides, news, and cultural insights, aimed at broadening public understanding and acceptance of psychedelics.

• Delic Radio:

A podcast platform where experts discuss various aspects of the psychedelic space, including the latest news, scientific developments, cultural shifts, medicinal breakthroughs, current affairs, and policy changes, enhancing the discourse surrounding psychedelics.

• Ketamine Infusion Treatment Clinics:

Delic Holdings Corp. owns and operates fifteen ketamine infusion treatment clinics across its operational territories. These clinics are dedicated to offering cutting-edge treatments for patients, harnessing the therapeutic potential of ketamine in addressing mental health conditions.

• Research and Development:

The company is deeply invested in the creation and development of intellectual property focusing on cannabis and psychedelics. Its R&D efforts are aimed at pioneering new treatments and understanding within these fields, potentially setting new standards for medicinal psychedelics.